California-headquartered Nasdaq-listed Masimo, a global leader in innovative non-invasive monitoring technologies, on Monday launched Rad-97 Pulse-CO Oximeter and the next generation Sedline Brain Function Monitoring in India.
Masimo Founder and CEO Joe Kiani said, “The Indian healthcare sector recognises the need for technologies that help their clinicians get the best results. We will continue to invest in India and strive to make our technologies and products as accessible as possible.”
Rad-97 offers the same upgradeable rainbow SET technology as the Radical-7 Pulse CO-Oximeter, in a versatile, standalone monitor configuration. Using Rad-97, clinicians can monitor such rainbow measurements as total hemoglobin (SpHb) and PVi, Kiani said.
GET IT 
Comments (+)